Catalan
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
ginsenoside a 1/càncer
L'enllaç es desa al porta-retalls
10 resultats
Composition for preventing or treating liver cancer containing ginsenoside F2
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
This application claims the benefit of Korean Patent Application No 10-2016-0099978, filed Aug. 5, 2016, the entirety of which is incorporated herein by reference.
TECHNICAL FIELD
The present invention relates to a pharmaceutical composition for preventing or treating liver cancer containing
Composition for preventing and treating cancer-related fatigue, containing processed ginseng powder or processed ginseng extract having increased ginsenoside constituent
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
CROSS REFERENCE TO RELATED APPLICATIONS
This application is a 35 U.S.C. .sctn. 371 National Phase Entry Application from PCT/KR2013/007852, filed on Aug. 30, 2013, and designating the United States, which is incorporated herein by reference in its entirety.
TECHNICAL FIELD
The present invention
Ginsenoside with anti-cancer activity and the preparation method thereof
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
FIELD OF INVENTION
This invention relates to a novel ginsenoside compound derived from ginsenoside Rh2, the preparation methods and the use thereof in treating cancers.
BACKGROUND OF INVENTION
In the past decades, a number of anti-cancer drugs have been discovered from natural products, which
Ginsenoside chemotherapy
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
FIELD OF THE INVENTION
The invention is in the field of therapeutic compositions and methods, particularly chemotherapy of cancer using ginsenosides.
BACKGROUND OF THE INVENTION
Panax ginseng has served as an important component of traditional Chinese medicine for thousands of years. Recently,
Method for preparing processed ginseng to obtain increased amount of ginsenoside RG5
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
This application claims priority upon Korean. Patent application Ser. No. KR 10-2005-00305 19 filed on Apr. 12, 2005, the contents of which are all herein incorporated by this reference in their entireties. All publications, patents, patent applications, databases and other references cited in this
Use of ginseng extract, ginsenoside and ginsenoside derivative in the preparation of medicine or health care product for treating cytomegalovirus infection disorders
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
TECHNICAL FIELD
The invention belongs to the field of medicines, and relates to a medicine or health food for treating human cytomegalovirus infection, particularly to application of ginseng (a traditional Chinese medicine) extracts and derivatives thereof in medicines or health foods for treating
Water solution of 20(R)-ginsenoside Rg3 pharmaceutical composition and process thereof
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
TECHNOLOGICAL FIELD OF THE INVENTION
This invention relates to a ginsenoside Rg3 pharmaceutical composition and process thereof.
TECHNOLOGICAL BACKGROUND OF THE INVENTION
Ginsenoside Rg3 is a tetracyclic-triterpene saponin compound existed in Ginseng, with a molecular weight of 784.13. There are two
Aqueous solution of 20(R)-ginsenoside RG3 pharmaceutical composition and process thereof
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
TECHNOLOGICAL FIELD OF THE INVENTION
This invention relates to a ginsenoside Rg3 pharmaceutical composition and process thereof.
TECHNOLOGICAL BACKGROUND OF THE INVENTION
Ginsenoside Rg3 is a tetracyclic-triterpene saponin compound existed in Ginseng, with a molecular weight of 784.13. There are two
20(R)-ginsenoside Rg3 polyacylated derivatives, preparation and application thereof
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
This application is the U.S. National phase application corresponding to PCT/CN2014/094726 which was assigned an international filing date of Dec. 23, 2014 and associated with publication WO 2016/095249 A1 and which claims priority to Chinese Application 2014107851724 filed on Dec. 17, 2014, the
Anticancer adjuvant containing panaxadiol ginsenocide compound
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
CROSS REFERENCE TO RELATED APPLICATIONS
This application is a U.S. National Stage Application filed under 35 U.S.C. .sctn. 371 and claims priority to International Application No. PCT/KR2015/006832, filed Jul. 2, 2015, which application claims priority to Korean Application No. 10-2015-0071477,
La base de dades d’herbes medicinals més completa avalada per la ciència
- Funciona en 55 idiomes
- Cures a base d'herbes recolzades per la ciència
- Reconeixement d’herbes per imatge
- Mapa GPS interactiu: etiqueta les herbes a la ubicació (properament)
- Llegiu publicacions científiques relacionades amb la vostra cerca
- Cerqueu herbes medicinals pels seus efectes
- Organitzeu els vostres interessos i estigueu al dia de les novetats, els assajos clínics i les patents
Escriviu un símptoma o una malaltia i llegiu sobre herbes que us poden ajudar, escriviu una herba i vegeu malalties i símptomes contra els quals s’utilitza.
* Tota la informació es basa en investigacions científiques publicades
